Brind.

Jim Cramer highlighted Incyte as a top S&P 500 winner on June 30, 2025.

1 report, 0 independent Updated Jun 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Incyte Jim Cramer

Keep exploring

The entities involved

Incyte
American pharmaceutical company
- Genmab and Incyte have entered into a collaboration to evaluate new cancer treatments.Sat 11:54
- Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.Sat 08:28
Jim Cramer
American stockbroker, television personality, author
- Fed rate hikes trigger market sell-offs, prompting Jim Cramer to advise selling while Elon Musk enters the telecom sector.Sat 19:55
- Cramer discussed CVS's turnaround efforts, noting that the company benefits from Trump-era tariffs.Sat 14:36

Related events

Coverage

Newest first; wire copies grouped

Jun 30Unknown outlet